<?xml version="1.0" encoding="UTF-8"?>
<drug type="biotech" created="2019-02-27" updated="2019-11-02">
  <drugbank-id primary="true">DB14740</drugbank-id>
  <name>Hyaluronidase</name>
  <description/>
  <cas-number>9001-54-1</cas-number>
  <unii>8KOG53Z5EM</unii>
  <groups>
    <group>approved</group>
  </groups>
  <general-references>
    <articles/>
    <textbooks/>
    <links/>
    <attachments/>
  </general-references>
  <synthesis-reference/>
  <indication/>
  <pharmacodynamics/>
  <mechanism-of-action/>
  <toxicity/>
  <metabolism/>
  <absorption/>
  <half-life/>
  <protein-binding/>
  <route-of-elimination/>
  <volume-of-distribution/>
  <clearance/>
  <classification>
    <description/>
    <direct-parent>Peptides</direct-parent>
    <kingdom>Organic Compounds</kingdom>
    <superclass>Organic Acids</superclass>
    <class>Carboxylic Acids and Derivatives</class>
    <subclass>Amino Acids, Peptides, and Analogues</subclass>
  </classification>
  <salts/>
  <synonyms>
    <synonym language="spanish" coder="inn">Hialuronidasa</synonym>
    <synonym language="english" coder="inn">Hyaluronidase</synonym>
    <synonym language="english" coder="">Hyaluronidase (bovine)</synonym>
    <synonym language="english" coder="">Hyaluronidase bovine</synonym>
    <synonym language="english" coder="">Hyaluronidase, bovine</synonym>
    <synonym language="latin" coder="inn">Hyaluronidasum</synonym>
    <synonym language="english" coder="">Hyaluronoglucosaminidase</synonym>
  </synonyms>
  <products>
    <product>
      <name>Amphadase</name>
      <labeller>Amphastar Pharmaceuticals, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>0548-9090</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2004-10-26</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection</dosage-form>
      <strength>150 [USP'U]/1mL</strength>
      <route>Subcutaneous</route>
      <fda-application-number>NDA021665</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Hydase</name>
      <labeller>Akorn, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>17478-560</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2015-11-05</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>150 [USP'U]/1mL</strength>
      <route>Infiltration; Interstitial; Intramuscular; Intraocular; Retrobulbar; Subcutaneous</route>
      <fda-application-number>NDA021716</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Rituxan Hycela</name>
      <labeller>Genentech, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>50242-109</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2017-06-22</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength/>
      <route>Subcutaneous</route>
      <fda-application-number>BLA761064</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Rituxan Hycela</name>
      <labeller>Genentech, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>50242-108</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2017-06-22</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength/>
      <route>Subcutaneous</route>
      <fda-application-number>BLA761064</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Wydase Inj 150unit/ml</name>
      <labeller>Wyeth Ltd.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00036307</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1954-12-31</started-marketing-on>
      <ended-marketing-on>1996-09-10</ended-marketing-on>
      <dosage-form>Liquid</dosage-form>
      <strength/>
      <route>Infiltration; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Wydase Injection Liq 150 Units/ml</name>
      <labeller>Wyeth Ayerst Canada Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02041278</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1994-12-31</started-marketing-on>
      <ended-marketing-on>2002-06-10</ended-marketing-on>
      <dosage-form>Liquid</dosage-form>
      <strength/>
      <route>Infiltration; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
  </products>
  <international-brands/>
  <mixtures>
    <mixture>
      <name>Amphadase</name>
      <ingredients>Hyaluronidase</ingredients>
    </mixture>
    <mixture>
      <name>Rituxan Hycela</name>
      <ingredients>Hyaluronidase + Rituximab</ingredients>
    </mixture>
    <mixture>
      <name>Rituxan Hycela</name>
      <ingredients>Hyaluronidase + Rituximab</ingredients>
    </mixture>
    <mixture>
      <name>Hydase</name>
      <ingredients>Hyaluronidase</ingredients>
    </mixture>
    <mixture>
      <name>Wydase Inj 150unit/ml</name>
      <ingredients>Hyaluronidase</ingredients>
    </mixture>
    <mixture>
      <name>Wydase Injection Liq 150 Units/ml</name>
      <ingredients>Hyaluronidase</ingredients>
    </mixture>
  </mixtures>
  <packagers/>
  <manufacturers/>
  <prices/>
  <categories>
    <category>
      <category>Blood and Blood Forming Organs</category>
      <mesh-id/>
    </category>
    <category>
      <category>Carbon-Oxygen Lyases</category>
      <mesh-id>D019757</mesh-id>
    </category>
    <category>
      <category>Enzymes</category>
      <mesh-id>D004798</mesh-id>
    </category>
    <category>
      <category>Enzymes and Coenzymes</category>
      <mesh-id>D045762</mesh-id>
    </category>
    <category>
      <category>Glycoside Hydrolases</category>
      <mesh-id>D006026</mesh-id>
    </category>
    <category>
      <category>Hyaluronoglucosaminidase, antagonists &amp; inhibitors</category>
      <mesh-id/>
    </category>
    <category>
      <category>Hydrolases</category>
      <mesh-id>D006867</mesh-id>
    </category>
    <category>
      <category>Lyases</category>
      <mesh-id>D008190</mesh-id>
    </category>
    <category>
      <category>Polysaccharide-Lyases</category>
      <mesh-id>D011133</mesh-id>
    </category>
  </categories>
  <affected-organisms/>
  <dosages>
    <dosage>
      <form>Injection</form>
      <route>Subcutaneous</route>
      <strength>150 [USP'U]/1mL</strength>
    </dosage>
    <dosage>
      <form>Injection, solution</form>
      <route>Infiltration; Interstitial; Intramuscular; Intraocular; Retrobulbar; Subcutaneous</route>
      <strength>150 [USP'U]/1mL</strength>
    </dosage>
    <dosage>
      <form>Injection, solution</form>
      <route>Subcutaneous</route>
      <strength/>
    </dosage>
    <dosage>
      <form>Liquid</form>
      <route>Infiltration; Subcutaneous</route>
      <strength/>
    </dosage>
  </dosages>
  <atc-codes>
    <atc-code code="B06AA03">
      <level code="B06AA">Enzymes</level>
      <level code="B06A">OTHER HEMATOLOGICAL AGENTS</level>
      <level code="B06">OTHER HEMATOLOGICAL AGENTS</level>
      <level code="B">BLOOD AND BLOOD FORMING ORGANS</level>
    </atc-code>
  </atc-codes>
  <ahfs-codes/>
  <pdb-entries/>
  <patents/>
  <food-interactions/>
  <drug-interactions/>
  <sequences/>
  <experimental-properties/>
  <external-identifiers>
    <external-identifier>
      <resource>Drugs Product Database (DPD)</resource>
      <identifier>6039</identifier>
    </external-identifier>
    <external-identifier>
      <resource>Wikipedia</resource>
      <identifier>Hyaluronidase</identifier>
    </external-identifier>
  </external-identifiers>
  <external-links/>
  <pathways/>
  <reactions/>
  <snp-effects/>
  <snp-adverse-drug-reactions/>
  <targets/>
  <enzymes/>
  <carriers/>
  <transporters/>
</drug>